{"database": "lobbying", "table": "lobbying_activities", "rows": [[1450398, "434d2e97-368f-494c-a67e-f371a0d2f7cd", "Q3", "AMERICAN ASSOCIATION OF NURSE PRACTITIONERS", 401040928, "AMERICAN ASSOCIATION OF NURSE PRACTITIONERS", 2013, "third_quarter", "PHA", "Legislation and policies relating to:\nFDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substance\nH.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drugH.R. 1919 - Safeguarding America's Pharmaceuticals Act\nS. 621  Safe Prescribing Act\nS. 959  Pharmaceutical Compounding Quality and Accountability Act\nH.R. 3089  Compounding Clarity Act\nH.R. 3204  Drug Quality and Security Act", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office", null, 84089, 0, 0, "2013-10-18T11:25:44.733000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1450398"], "units": {}, "query_ms": 104.18256896082312, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}